Skip to content

Clinical trials

Waldenstrom Macroglobulinemia trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Country / region: Denmark Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20102
20121
20211
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center3
Anne Louise Tølbøll Sørensen1
Eli Lilly and Company1
Karyopharm Therapeutics Inc1
Merck Sharp & Dohme LLC1
Rigshospitalet, Denmark1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia8
Lymphoma, Non-Hodgkin5
Multiple Myeloma5
Hematologic Neoplasms4
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Mantle-Cell4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hodgkin Disease3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3

Trials

Showing 76 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.